FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4300817227> ?p ?o ?g. }

• W4300817227 abstract "Abstract This study aims to investigate the prognostic value of the systemic immune-inflammation index (SII)and its impact on survival in patients with metastatic renal cell carcinoma (mRCC). A total of 706patients with mRCC treated with tyrosine kinase inhibitors (TKIs)between January 2007 and June 2020 (i.e., sunitinib, pazopanib) were included in this study. SII was calculated in 621 patients with the following formula:[neutrophil (cellsx10 9 /L) x platelet (cellsx10 9 /L)] / lymphocyte (cellsx10 9 /L).All patients were classified into SII-high and SII-low groups based on the cut-off value of SII at 756, which was the median SII level of our study group. The minimal follow-up duration was 10 months in all cohorts. The median age of patients was 60 (interquartile range (IQR):53–67) years. Three out of four patients were male. The majority of patients (85.7%) had clear cell histology, and sarcomatoid differentiation was observed in 16.9% of all patients. There were 311 and 310 patients in the SII-low and SII-high groups, respectively. In general, baseline characteristics were similar in each group. However, the rate of patients treated with sunitinib (63.3% vs. 49.0%, p < 0.001) and those who underwent nephrectomy (83.6% vs. 64.2%, p < 0.001) was higher in the SII-low group than in the SII-high group. On the other hand, patients with the IMDC poorrisk (31.6% vs. 8.0%, p < 0.001), those with bone (51.8% vs. 32.2%, p < 0.001) or central nervous system (12.9% vs. 5.8%, p = 0.026) metastasis, and those with Eastern Cooperative Oncology Group(ECOG) 2–4 performance score (28.1% vs.17.7%, p = 0.002) were more common in the SII-high group than in the SII-low group. The median overall survival (OS) was longer in the SII-low group than in the SII-high group (34.6 months vs. 14.5 months, p < 0.001). Similarly, the median progression-free survival (PFS) was longer in the SII-low group than in the SII-high group (18.0 months vs. 7.7 months, p < 0.001).In multivariableanalysis, SII was an independent prognostic factor for OS (hazard ratio (HR):1.39, 95% confidence interval (CI):1.05–1.85, p = 0.01) and PFS (HR:1.60, 95% CI:1.24–2.05, p < 0.001).Pre-treatment level of high SII might be considered a predictor of poor prognosisin patients with mRCC treated with TKIs." @default.
• W4300817227 created "2022-10-04" @default.
• W4300817227 creator A5001724116 @default.
• W4300817227 creator A5010059818 @default.
• W4300817227 creator A5011701013 @default.
• W4300817227 creator A5012083790 @default.
• W4300817227 creator A5012195445 @default.
• W4300817227 creator A5013823331 @default.
• W4300817227 creator A5013941417 @default.
• W4300817227 creator A5019461247 @default.
• W4300817227 creator A5028500628 @default.
• W4300817227 creator A5033323622 @default.
• W4300817227 creator A5052112651 @default.
• W4300817227 creator A5056352422 @default.
• W4300817227 creator A5058897783 @default.
• W4300817227 creator A5063630319 @default.
• W4300817227 creator A5064592414 @default.
• W4300817227 creator A5067436525 @default.
• W4300817227 creator A5071613646 @default.
• W4300817227 creator A5083927273 @default.
• W4300817227 creator A5084659231 @default.
• W4300817227 date "2022-10-03" @default.
• W4300817227 modified "2023-10-18" @default.
• W4300817227 title "The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors" @default.
• W4300817227 cites W1982906652 @default.
• W4300817227 cites W1986188440 @default.
• W4300817227 cites W1992532818 @default.
• W4300817227 cites W2018038784 @default.
• W4300817227 cites W2078419070 @default.
• W4300817227 cites W2099752220 @default.
• W4300817227 cites W2107934474 @default.
• W4300817227 cites W2123105952 @default.
• W4300817227 cites W2143813821 @default.
• W4300817227 cites W2149456801 @default.
• W4300817227 cites W2281395530 @default.
• W4300817227 cites W2530956228 @default.
• W4300817227 cites W2730495368 @default.
• W4300817227 cites W2754430781 @default.
• W4300817227 cites W2767077750 @default.
• W4300817227 cites W2793054258 @default.
• W4300817227 cites W2907019347 @default.
• W4300817227 cites W2911188335 @default.
• W4300817227 cites W2913745075 @default.
• W4300817227 cites W2922310334 @default.
• W4300817227 cites W2937003735 @default.
• W4300817227 cites W3011682129 @default.
• W4300817227 cites W3033085044 @default.
• W4300817227 cites W3034071556 @default.
• W4300817227 cites W3128646645 @default.
• W4300817227 cites W3131063362 @default.
• W4300817227 cites W3132830564 @default.
• W4300817227 cites W3134949580 @default.
• W4300817227 cites W3137527432 @default.
• W4300817227 cites W3137616542 @default.
• W4300817227 cites W3214392509 @default.
• W4300817227 doi "https://doi.org/10.1038/s41598-022-20056-3" @default.
• W4300817227 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36192500" @default.
• W4300817227 hasPublicationYear "2022" @default.
• W4300817227 type Work @default.
• W4300817227 citedByCount "2" @default.
• W4300817227 countsByYear W43008172272023 @default.
• W4300817227 crossrefType "journal-article" @default.
• W4300817227 hasAuthorship W4300817227A5001724116 @default.
• W4300817227 hasAuthorship W4300817227A5010059818 @default.
• W4300817227 hasAuthorship W4300817227A5011701013 @default.
• W4300817227 hasAuthorship W4300817227A5012083790 @default.
• W4300817227 hasAuthorship W4300817227A5012195445 @default.
• W4300817227 hasAuthorship W4300817227A5013823331 @default.
• W4300817227 hasAuthorship W4300817227A5013941417 @default.
• W4300817227 hasAuthorship W4300817227A5019461247 @default.
• W4300817227 hasAuthorship W4300817227A5028500628 @default.
• W4300817227 hasAuthorship W4300817227A5033323622 @default.
• W4300817227 hasAuthorship W4300817227A5052112651 @default.
• W4300817227 hasAuthorship W4300817227A5056352422 @default.
• W4300817227 hasAuthorship W4300817227A5058897783 @default.
• W4300817227 hasAuthorship W4300817227A5063630319 @default.
• W4300817227 hasAuthorship W4300817227A5064592414 @default.
• W4300817227 hasAuthorship W4300817227A5067436525 @default.
• W4300817227 hasAuthorship W4300817227A5071613646 @default.
• W4300817227 hasAuthorship W4300817227A5083927273 @default.
• W4300817227 hasAuthorship W4300817227A5084659231 @default.
• W4300817227 hasBestOaLocation W43008172271 @default.
• W4300817227 hasConcept C119060515 @default.
• W4300817227 hasConcept C126322002 @default.
• W4300817227 hasConcept C2777472916 @default.
• W4300817227 hasConcept C2778439243 @default.
• W4300817227 hasConcept C2779490328 @default.
• W4300817227 hasConcept C2780091579 @default.
• W4300817227 hasConcept C2780227381 @default.
• W4300817227 hasConcept C57742111 @default.
• W4300817227 hasConcept C71924100 @default.
• W4300817227 hasConcept C90924648 @default.
• W4300817227 hasConceptScore W4300817227C119060515 @default.
• W4300817227 hasConceptScore W4300817227C126322002 @default.
• W4300817227 hasConceptScore W4300817227C2777472916 @default.
• W4300817227 hasConceptScore W4300817227C2778439243 @default.
• W4300817227 hasConceptScore W4300817227C2779490328 @default.
• W4300817227 hasConceptScore W4300817227C2780091579 @default.
• W4300817227 hasConceptScore W4300817227C2780227381 @default.
• W4300817227 hasConceptScore W4300817227C57742111 @default.

• next